Physician profile
Gary M Dalley
NPI 1629071873
$1,134.23
in general payments reported to CMS, 2019-2025
17 companies · $97.10 in 2025
The $97.10 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $12.17 · 2021: $44.15 · 2022: $330 · 2023: $198 · 2024: $186 · 2025: $97.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $497.47 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $143.78 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $96.58 | 2019-2025 | |
| Dexcom, INC. | $89.78 | 2022-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $52.26 | 2019-2022 | |
| Medtronic, INC. | $38.81 | 2024 | Interstim |
| Abbvie INC. | $35.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $30.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.58 | 2023 | Tradjenta, Synjardy, Jardiance |
| Dynavax Technologies Corporation | $20.28 | 2023 | Heplisav-B |
| Astellas Pharma US INC | $17.25 | 2023 | Veozah |
| Sanofi Pasteur INC. | $17.01 | 2023 | |
| Nevro Corp. | $15.98 | 2023 | Senza |
| Lilly USA, LLC | $15.88 | 2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $14.42 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12.30 | 2022 | |
| Medtronic USA, INC. | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Dalley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.